_the-propel-clinical-trial-exploring-olaparib-plus-abiraterone-in-mcrpc-preview-1.jpg "The PROpel clinical trial exploring olaparib plus abiraterone in mCRPC from olaparib prostate cancer Video Screenshot Preview 1")
Gallery_the-propel-clinical-trial-exploring-olaparib-plus-abiraterone-in-mcrpc-preview-3.jpg "The PROpel clinical trial exploring olaparib plus abiraterone in mCRPC from olaparib prostate cancer Video Screenshot Preview 3")
Gallery_the-propel-clinical-trial-exploring-olaparib-plus-abiraterone-in-mcrpc-preview-hqdefault.jpg "The PROpel clinical trial exploring olaparib plus abiraterone in mCRPC from olaparib prostate cancer Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 1 minute 45 seconds
👁 View: 257 times
Play Audio:👁 View: 257 times
Description:
VJOncology
VJOncology
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_parpi-olaparib-for-the-targeted-treatment-of-metastatic-prostate-cancer.webp "Vall d'Hebron Institute of Oncology - VHIO")
_rucaparib-and-olaparib-two-new-treatments-approved-for-advanced-prostate-cancer-124-pcri.webp "Prostate Cancer Research Institute")
⏲ 5 minutes 15 seconds 👁 1.8K
_olaparib-plus-abiraterone-for-mcrpc-are-biomarkers-necessary.webp "VJOncology")
_olaparib-plus-abiraterone-could-be-a-new-first-line-treatment-option-for-mcrpc-124-fred-saad.webp "Medicine Matters oncology")
⏲ 3 minutes 41 seconds 👁 193
_exciting-times-for-hormone-sensitive-prostate-cancer-treatment.webp "VJOncology")
_brca-amp-parp-inhibitors-targeted-chemotherapy-124-markscholzmd-alexscholz-pcri.webp "Prostate Cancer Research Institute")
⏲ 11 minutes 49 seconds 👁 2K
_recent-updates-in-prostate-cancer-stampede-vision-amp-profound.webp "VJOncology")
_propel-olaparib-plus-abiraterone-as-1l-treatment-for-metastatic-crpc.webp "VJOncology")
_parpi-olaparib-for-the-targeted-treatment-of-metastatic-prostate-cancer.jpg)
_rucaparib-and-olaparib-two-new-treatments-approved-for-advanced-prostate-cancer-124-pcri.jpg)
_olaparib-plus-abiraterone-for-mcrpc-are-biomarkers-necessary.jpg)
_olaparib-plus-abiraterone-could-be-a-new-first-line-treatment-option-for-mcrpc-124-fred-saad.jpg)
_exciting-times-for-hormone-sensitive-prostate-cancer-treatment.jpg)
_brca-amp-parp-inhibitors-targeted-chemotherapy-124-markscholzmd-alexscholz-pcri.jpg)
_recent-updates-in-prostate-cancer-stampede-vision-amp-profound.jpg)
_propel-olaparib-plus-abiraterone-as-1l-treatment-for-metastatic-crpc.jpg)
![[+]](/images/menu.gif){kind=small}